Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in the Human Hypothalamus

Journal of Neuroendocrinology

Volumn 25, Issue 5, 2013, Pages 425-432

  Bisschop, P H ^a   Dekker, M J H J ^b   Osterthun, W ^a   Kwakkel, J ^a   Anink, J J ^c   Boelen, A ^a   Unmehopa, U A ^c   Koper, J W ^b   Lamberts, S W J ^b   Stewart, P M ^d   Swaab, D F ^c   Fliers, E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Human; Hypothalamus; Infundibular nucleus; Paraventricular nucleus

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; OXYTOCIN;

ARTICLE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; HYPOTHALAMUS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84875824479     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12017     Document Type: Article

References (25)

1. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. 11{beta}-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831-866.
2. Wyrwoll CS, Holmes MC, Seckl JR. 11[beta]-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol 2011; 32: 265-286.
3. Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci 2009; 63: 613-622.
4. Moisan MP, Seckl JR, Edwards CRW. 11{beta}-hydroxysteroid dehydrogenase bioactivity and messenger rna expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology 1990; 127: 1450-1455.
5. Sandeep TC, Yau JLW, MacLullich AMJ, Noble J, Deary IJ, Walker BR, Seckl JR. From the cover: 11{beta}-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci USA 2004; 101: 6734-6739.
6. Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB, Stewart PM. Expression of 11{beta}-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J Clin Endocrinol Metab 2001; 86: 2728-2733.
7. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, Trajkovic V, Campbell CC, Xu D, Liew FY. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001; 166: 6633-6639.
8. Goldstone AP, Unmehopa UA, Bloom SR, Swaab DF. Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab 2002; 87: 927-937.
9. Purba JS, Hofman MA, Portegies P, Troost D, Swaab DF. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 1993; 116: 795-809.
10. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
11. Hou-Yu A, Lamme AT, Zimmerman EA, Silverman AJ. Comparative distribution of vasopressin and oxytocin neurons in the rat brain using a double-label procedure. Neuroendocrinology 1986; 44: 235-246.
12. Hou-Yu A, Ehrlich PH, Valiquette G, Engelhardt DL, Sawyer WH, Nilaver G, Zimmerman EA. A monoclonal antibody to vasopressin: preparation, characterization, and application in immunocytochemistry. J Histochem Cytochem 1982; 30: 1249-1260.
13. van Oers JWAM, Tilders FJH, Berkenbosch F. Characterization and biological activity of a rat monoclonal antibody to rat/human corticotropin-releasing factor. Endocrinology 1989; 124: 1239-1246.
14. Wu YH, Zhou JN, Balesar R, Unmehopa U, Bao A, Jockers R, Van Heerikhuize J, Swaab DF. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J Comp Neurol 2006; 499: 897-910.
15. Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab 1998; 83: 2066-2073.
16. Rosenstock J, Banarer S, Fonseca VA, Inzucchi SE, Sun W, Yao W, Hollis G, Flores R, Levy R, Williams WV, Seckl JR, Huber R, for the INCB. The 11{beta}-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care 2010; 33: 1516-1522.
17. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC. Intracellular regeneration of glucocorticoids by 11{beta}-hydroxysteroid dehydrogenase (11{beta}-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11{beta}-HSD-1-deficient mice. Endocrinology 2001; 142: 114-120.
18. Farooqi IS, Keogh JM, Yeo GSH, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095.
19. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF. Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res 1994; 665: 201-212.
20. Gyengesi E, Liu ZW, D'Agostino G, Gan G, Horvath TL, Gao XB, Diano S. Corticosterone regulates synaptic input organization of pomc and npy/agrp neurons in adult mice. Endocrinology 2010; 151: 5395-5402.
21. Lawson AJ, Walker EA, Lavery GG, Bujalska IJ, Hughes B, Arlt W, Stewart PM, Ride JP. Cortisone-reductase deficiency associated with heterozygous mutations in 11{beta}-hydroxysteroid dehydrogenase type 1. Proc Natl Acad Sci USA 2011; 108: 4111-4116.
22. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci Res 1996; 26: 235-269.
23. Aronsson M, Fuxe K, Dong Y, Agnati LF, Okret S, Gustafsson JA. Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Natl Acad Sci USA 1988; 85: 9331-9335.
24. Cintra A, Fuxe K, Härfstrand A, Agnati LF, Wikström AC, Okret S, Vale W, Gustafsson JA. Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di- and telencephalon. Neurosci Lett 1987; 77: 25-30.
25. McEwen BS, De Kloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66: 1121-1188.